Fibrinogen Thrombin Sealant

At the bleeding site, thrombin drives the conversion of soluble fibrinogen into fibrin. The resulting strands form a local network rather than requiring the entire coagulation sequence to occur at that surface. Because this reproduces the final stage of natural coagulation, it provides a direct route to clot formation where the sealant is placed.

Factor XIII and calcium help stabilize the newly formed fibrin network. This stabilization changes an initially formed clot into a more mechanically secure seal at the treated surface. Their contribution matters because the desired outcome is not only fibrin formation, but also sufficient structural integrity to support bleeding control and tissue sealing during a procedure.

The sealant supplies a local fibrin-forming mechanism at the bleeding site, so clot formation does not rely entirely on the patient’s platelet function or clotting factors. It therefore complements natural hemostasis rather than reproducing every upstream coagulation step. This distinction is particularly relevant when conventional biological clot formation may not provide adequate local control.

Application places fibrinogen and thrombin at the area requiring control, allowing the conversion reaction to occur locally. Fibrin then develops at the treated surface, while factor XIII and calcium support network stabilization. The practical result is a localized clot that can both reduce bleeding and help seal tissue during medical treatment.

It is useful when bleeding surfaces or tissue interfaces are difficult to manage with conventional sutures or cautery. The sealant can be placed directly on the relevant area, where its fibrin-forming reaction supports local hemostasis and tissue sealing. Its value therefore lies in addressing sites where mechanical closure or heat-based control is challenging.

The described applications include surgery, trauma care, and wound management. In these settings, the sealant may help reduce blood loss, seal tissue surfaces, and support healing. Its local mechanism also provides a way to address bleeding or tissue separation at the treatment site without depending entirely on systemic platelet and clotting-factor activity.